A detailed history of Fora Capital, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 11,483 shares of STIM stock, worth $48,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,483
Holding current value
$48,802
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$1.49 - $5.54 $17,109 - $63,615
11,483 New
11,483 $42,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $115M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.